VERA THERAPEUTICS INC
NASDAQ: VERA (Vera Therapeutics, Inc.)
Kemas kini terakhir: 3 jam lalu33.60
-0.18 (-0.53%)
| Penutupan Terdahulu | 33.78 |
| Jumlah Dagangan | 2,027,441 |
| Harga / Buku (P/B) | 5.97 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -3.00 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 10.18% |
| Nisbah Semasa (MRQ) | 27.68 |
| Aliran Tunai Operasi (OCF TTM) | -155.26 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -97.14 M |
| Pulangan Atas Aset (ROA TTM) | -23.46% |
| Pulangan Atas Ekuiti (ROE TTM) | -39.49% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Vera Therapeutics, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.25 |
|
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 3.97% |
| % Dimiliki oleh Institusi | 112.39% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Avoro Capital Advisors Llc | 30 Jun 2026 | 5,723,888 |
| Deep Track Capital, Lp | 30 Jun 2026 | 4,000,000 |
| Kynam Capital Management, Lp | 30 Jun 2026 | 2,890,059 |
| Sofinnova Investments, Inc. | 30 Jun 2026 | 2,793,987 |
| Eversept Partners, Lp | 30 Jun 2026 | 2,212,770 |
| Integral Health Asset Management, Llc | 30 Jun 2026 | 1,750,000 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| FORDYCE MARSHALL | - | 35.66 | -18,500 | -659,710 |
| Jumlah Keseluruhan Kuantiti Bersih | -18,500 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -659,710 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 35.66 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| FORDYCE MARSHALL | Pegawai | 02 Sep 2026 | Jual automatik (-) | 18,500 | 35.66 | 659,710 |
| FORDYCE MARSHALL | Pegawai | 02 Sep 2026 | Pelaksanaan pilihan | 18,500 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |